TP53 and cancer: In this study, the proportion of cells with high ROS production during pKAL treatment was less in p53-wild HCT116 cells than in p53-null cells, whereas the proportion of dead cells was larger, suggesting that the intracellular ROS levels and signals could influence the fate of cancer cells, but not the high ROS production itself alone.